Duaklir Pressair

List of products in the National Drug Code with proprietary name duaklir pressair. This product is used to control and prevent symptoms (such as wheezing and shortness of breath) caused by ongoing lung disease (chronic obstructive pulmonary disease-COPD, which includes chronic bronchitis and emphysema). Controlling symptoms of breathing problems helps you stay active. This inhaler contains 2 medications: aclidinium and formoterol. Both drugs work by relaxing the muscles around the airways so that they open up and you can breathe more easily. Aclidinium belongs to a class of drugs known as anticholinergics, and formoterol belongs to a class of drugs known as long-acting beta agonists (LABAs). Both drugs are also known as bronchodilators. This medication must be used regularly to be effective. It does not work right away and should not be used to relieve sudden shortness of breath. If sudden breathing problems occur, use your quick-relief inhaler as prescribed. This medication is not approved to treat asthma.

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Labeler Name Product Type
0310-0900Duaklir Pressair Aclidinium Bromide And Formoterol FumaratePowder, MeteredRespiratory (inhalation)Astrazeneca Pharmaceuticals LpHuman Prescription Drug
70515-001Duaklir Pressair Aclidinium Bromide And Formoterol FumaratePowder, MeteredRespiratory (inhalation)Covis Pharma Us, IncHuman Prescription Drug